Clinical Trial

Tacrolimus in Pregnancy

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To create a formula that adjusts tacrolimus blood levels. This is needed because pregnant patients have higher levels of unbound tacrolimus. The adjusted formula will give a more accurate measure of the active drug in pregnant uterus transplant patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-12; most recent amendment 2026-04-24.
Trial Details
NCT Number NCT07422012
Lead Sponsor Baylor Research Institute
Collaborators: Children's Hospital Medical Center, Cincinnati, University of Washington
Conditions Unbound Tacrolimus in Pregnant Uterus Transplant Recipients, Whole Blood Tacrolimus in Pregnant Uterus Transplant Recipients
Enrollment 55 participants
Start Date 2026-05-31
Primary Completion 2028-02 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-28